WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹768 Cr | ₹770 Cr | ₹882 Cr | ₹866 Cr | ₹840 Cr |
What is the latest Contingent Liabilities ratio of WOCKHARDT ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹768 Cr |
| Mar2025 | ₹770 Cr |
| Mar2024 | ₹882 Cr |
| Mar2023 | ₹866 Cr |
| Mar2022 | ₹840 Cr |
How is Contingent Liabilities of WOCKHARDT Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹768 Cr | -0.26 | |
| Mar2025 | ₹770 Cr | -12.71 | |
| Mar2024 | ₹882 Cr | 1.87 | |
| Mar2023 | ₹866 Cr | 3.13 | |
| Mar2022 | ₹840 Cr | - | |
Compare Contingent Liabilities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹29,739.9 Cr | -5.3% | -1.7% | 21.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | -1.2% | -2.2% | 15.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹227,958.0 Cr | 1% | 16.3% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,990.0 Cr | 3.2% | -0.8% | 38.6% | Stock Analytics | |
| CIPLA | ₹116,141.0 Cr | -0.9% | 1.6% | -9.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,604.4 Cr | -1.7% | -0.1% | -6.5% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -5.3% |
-1.7% |
21.5% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
You may also like the below Video Courses